The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
Follow CC
Alert me
The Chemours Company (CC) Operating cash flow
The Chemours Company's operating cash flow for fiscal 2025 was $264.0M, compared with −$633.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $400.0M. Over the past ten years it has ranged from −$633.0M (fiscal 2024) to $1.1B (fiscal 2018); the current reading is higher than 27% of that period. The Chemours Company ranks 19th of 59 Specialty Chemicals companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $264.0M | — |
| FY2024 | −$633.0M | — |
| FY2023 | $556.0M | (26.36%) |
| FY2022 | $755.0M | (7.25%) |
| FY2021 | $814.0M | 0.87% |
| FY2020 | $807.0M | 24.15% |
| FY2019 | $650.0M | (42.98%) |
| FY2018 | $1.1B | 78.13% |
| FY2017 | $640.0M | 7.74% |
| FY2016 | $594.0M | 226.37% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $149.0M | (5.70%) |
| Jun 2026 | $158.0M | — |
| Mar 2026 | −$44.0M | — |
| Dec 2025 | $137.0M | (6.16%) |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| CC The Chemours Company | $400.0M |
| FUL H. B. Fuller Company compare | $289.4M |
| MTX Minerals Technologies Inc. compare | $235.3M |
| NGVT Ingevity Corporation compare | $211.0M |
| SCL Stepan Company compare | $155.0M |
| WDFC WD-40 Company compare | $105.0M |
| IOSP Innospec Inc. compare | $103.6M |
| KWR Quaker Houghton compare | $94.1M |
| STDN Standard Nuclear Inc compare | — |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on CC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement